FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2747111954> ?p ?o ?g. }

• W2747111954 endingPage "1277" @default.
• W2747111954 startingPage "1269" @default.
• W2747111954 abstract "Dihydropyrimidine dehydrogenase (DPD) catabolises ∼85% of the administered dose of fluoropyrimidines. Functional DPYD gene variants cause reduced/abrogated DPD activity. DPYD variants analysis may help for defining individual patients’ risk of fluoropyrimidine-related severe toxicity. The TOSCA Italian randomised trial enrolled colon cancer patients for 3 or 6 months of either FOLFOX-4 or XELOX adjuvant chemotherapy. In an ancillary pharmacogenetic study, 10 DPYD variants (*2A rs3918290 G>A, *13 rs55886062 T>G, rs67376798 A>T, *4 rs1801158 G>A, *5 rs1801159 A>G, *6 rs1801160 G>A, *9A rs1801265 T>C, rs2297595 A>G, rs17376848 T>C, and rs75017182 C>G), were retrospectively tested for associations with ⩾grade 3 fluoropyrimidine-related adverse events (FAEs). An association analysis and a time-to-toxicity (TTT) analysis were planned. To adjust for multiple testing, the Benjamini and Hochberg’s False Discovery Rate (FDR) procedure was used. FAEs occurred in 194 out of 508 assessable patients (38.2%). In the association analysis, FAEs occurred more frequently in *6 rs1801160 A allele carriers (FDR=0.0083). At multivariate TTT analysis, significant associations were found for *6 rs1801160 A allele carriers (FDR<0.0001), *2A rs3918290 A allele carriers (FDR<0.0001), and rs2297595 GG genotype carriers (FDR=0.0014). Neutropenia was the most common FAEs (28.5%). *6 rs1801160 (FDR<0.0001), and *2A rs3918290 (FDR=0.0004) variant alleles were significantly associated with time to neutropenia. This study adds evidence on the role of DPYD pharmacogenetics for safety of patients undergoing fluoropyrimidine-based chemotherapy." @default.
• W2747111954 created "2017-08-31" @default.
• W2747111954 creator A5000261373 @default.
• W2747111954 creator A5008661123 @default.
• W2747111954 creator A5015936724 @default.
• W2747111954 creator A5018141422 @default.
• W2747111954 creator A5018196414 @default.
• W2747111954 creator A5021965265 @default.
• W2747111954 creator A5022553664 @default.
• W2747111954 creator A5023705158 @default.
• W2747111954 creator A5028269615 @default.
• W2747111954 creator A5028325185 @default.
• W2747111954 creator A5032278474 @default.
• W2747111954 creator A5032747123 @default.
• W2747111954 creator A5034356923 @default.
• W2747111954 creator A5037714306 @default.
• W2747111954 creator A5041059814 @default.
• W2747111954 creator A5041597689 @default.
• W2747111954 creator A5051613962 @default.
• W2747111954 creator A5053162229 @default.
• W2747111954 creator A5061179981 @default.
• W2747111954 creator A5070357793 @default.
• W2747111954 creator A5073589642 @default.
• W2747111954 creator A5074010450 @default.
• W2747111954 creator A5074263826 @default.
• W2747111954 creator A5079256460 @default.
• W2747111954 creator A5084773667 @default.
• W2747111954 creator A5086093217 @default.
• W2747111954 creator A5086719161 @default.
• W2747111954 creator A5087537525 @default.
• W2747111954 creator A5090814125 @default.
• W2747111954 creator A5091393421 @default.
• W2747111954 date "2017-08-24" @default.
• W2747111954 modified "2023-10-18" @default.
• W2747111954 title "Dihydropyrimidine dehydrogenase pharmacogenetics for predicting fluoropyrimidine-related toxicity in the randomised, phase III adjuvant TOSCA trial in high-risk colon cancer patients" @default.
• W2747111954 cites W1494740510 @default.
• W2747111954 cites W1510315517 @default.
• W2747111954 cites W1552917964 @default.
• W2747111954 cites W1774948393 @default.
• W2747111954 cites W1966968583 @default.
• W2747111954 cites W1982291105 @default.
• W2747111954 cites W1982529641 @default.
• W2747111954 cites W1982733535 @default.
• W2747111954 cites W1989511857 @default.
• W2747111954 cites W1994131735 @default.
• W2747111954 cites W2012427837 @default.
• W2747111954 cites W2021629895 @default.
• W2747111954 cites W2028444294 @default.
• W2747111954 cites W2038176250 @default.
• W2747111954 cites W2047544514 @default.
• W2747111954 cites W2098584035 @default.
• W2747111954 cites W2113414095 @default.
• W2747111954 cites W2130146901 @default.
• W2747111954 cites W2135759358 @default.
• W2747111954 cites W2160859576 @default.
• W2747111954 cites W2174633205 @default.
• W2747111954 cites W2270030389 @default.
• W2747111954 cites W2274849119 @default.
• W2747111954 cites W2288092988 @default.
• W2747111954 cites W2295455801 @default.
• W2747111954 cites W2334885885 @default.
• W2747111954 cites W2338977782 @default.
• W2747111954 cites W2411762199 @default.
• W2747111954 cites W2470575266 @default.
• W2747111954 cites W2507511969 @default.
• W2747111954 cites W2510653789 @default.
• W2747111954 cites W2514438964 @default.
• W2747111954 cites W2584708289 @default.
• W2747111954 cites W2606453095 @default.
• W2747111954 doi "https://doi.org/10.1038/bjc.2017.289" @default.
• W2747111954 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5709672" @default.
• W2747111954 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29065426" @default.
• W2747111954 hasPublicationYear "2017" @default.
• W2747111954 type Work @default.
• W2747111954 sameAs 2747111954 @default.
• W2747111954 citedByCount "47" @default.
• W2747111954 countsByYear W27471119542017 @default.
• W2747111954 countsByYear W27471119542018 @default.
• W2747111954 countsByYear W27471119542019 @default.
• W2747111954 countsByYear W27471119542020 @default.
• W2747111954 countsByYear W27471119542021 @default.
• W2747111954 countsByYear W27471119542022 @default.
• W2747111954 countsByYear W27471119542023 @default.
• W2747111954 crossrefType "journal-article" @default.
• W2747111954 hasAuthorship W2747111954A5000261373 @default.
• W2747111954 hasAuthorship W2747111954A5008661123 @default.
• W2747111954 hasAuthorship W2747111954A5015936724 @default.
• W2747111954 hasAuthorship W2747111954A5018141422 @default.
• W2747111954 hasAuthorship W2747111954A5018196414 @default.
• W2747111954 hasAuthorship W2747111954A5021965265 @default.
• W2747111954 hasAuthorship W2747111954A5022553664 @default.
• W2747111954 hasAuthorship W2747111954A5023705158 @default.
• W2747111954 hasAuthorship W2747111954A5028269615 @default.
• W2747111954 hasAuthorship W2747111954A5028325185 @default.
• W2747111954 hasAuthorship W2747111954A5032278474 @default.
• W2747111954 hasAuthorship W2747111954A5032747123 @default.
• W2747111954 hasAuthorship W2747111954A5034356923 @default.
• W2747111954 hasAuthorship W2747111954A5037714306 @default.

• next